Aprogen Healthcare & Games Inc Cash Flow Reinvestment Rate
Aprogen Healthcare & Games Inc cash flow reinvestment rate. Aprogen Healthcare & Games Inc (109960) has a Cash Flow Reinvestment Rate of 0.54x as of September 2025, reinvesting ₩375.00 Million (capex ₩0.00 plus investments ₩-375.00 Million) from operating cash flow of ₩699.57 Million. Explore Aprogen Healthcare & Games Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aprogen Healthcare & Games Inc (2013–2024)
Cash flow reinvestment rate of Aprogen Healthcare & Games Inc from 2013 to 2024. Historical reinvestment intensity for Aprogen Healthcare & Games Inc across 8 annual periods. Explore Aprogen Healthcare & Games Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Aprogen Healthcare & Games Inc Cash Flow Reinvestment Rate by Year (2013–2024)
Aprogen Healthcare & Games Inc cash flow reinvestment rate by year from 2013 to 2024. Year-by-year capital reinvestment analysis for Aprogen Healthcare & Games Inc. For the full cash flow conversion analysis, see Aprogen Healthcare & Games Inc (109960) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 11.05x | ₩52.01 Billion | ₩4.71 Billion | ₩81.90 Million | ▼ -81.1% |
| 2023 | 58.53x | ₩97.28 Billion | ₩1.66 Billion | ₩24.98 Million | ▲ +5378.0% |
| 2022 | 1.07x | ₩18.47 Billion | ₩17.28 Billion | ₩0.00 | ▼ -90.7% |
| 2020 | 11.54x | ₩39.08 Billion | ₩3.39 Billion | ₩29.97 Million | ▼ -48.0% |
| 2019 | 22.18x | ₩21.87 Billion | ₩986.07 Million | ₩96.26 Million | ▲ +4.0% |
| 2018 | 21.33x | ₩93.05 Billion | ₩4.36 Billion | ₩42.13 Million | ▼ -83.7% |
| 2017 | 131.23x | ₩96.41 Billion | ₩734.70 Million | ₩10.87 Billion | ▲ +31578.4% |
| 2013 | 0.41x | ₩503.42 Million | ₩1.22 Billion | ₩399.12 Million | — |